These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo. Guan H; Jia SF; Zhou Z; Stewart J; Kleinerman ES Clin Cancer Res; 2005 Mar; 11(5):2008-17. PubMed ID: 15756027 [TBL] [Abstract][Full Text] [Related]
25. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. Li B; Sharpe EE; Maupin AB; Teleron AA; Pyle AL; Carmeliet P; Young PP FASEB J; 2006 Jul; 20(9):1495-7. PubMed ID: 16754748 [TBL] [Abstract][Full Text] [Related]
26. EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins. Potikyan G; Savene RO; Gaulden JM; France KA; Zhou Z; Kleinerman ES; Lessnick SL; Denny CT Cancer Res; 2007 Jul; 67(14):6675-84. PubMed ID: 17638877 [TBL] [Abstract][Full Text] [Related]
27. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. Amano K; Okigaki M; Adachi Y; Fujiyama S; Mori Y; Kosaki A; Iwasaka T; Matsubara H J Mol Cell Cardiol; 2004 Apr; 36(4):469-80. PubMed ID: 15081307 [TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family. Dalal S; Berry AM; Cullinane CJ; Mangham DC; Grimer R; Lewis IJ; Johnston C; Laurence V; Burchill SA Clin Cancer Res; 2005 Mar; 11(6):2364-78. PubMed ID: 15788688 [TBL] [Abstract][Full Text] [Related]
29. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma. Werner S; Mendoza A; Hilger RA; Erlacher M; Reichardt W; Lissat A; Konanz C; Uhl M; Niemeyer CM; Khanna C; Kontny U Cancer Chemother Pharmacol; 2008 Jun; 62(1):19-31. PubMed ID: 17823799 [TBL] [Abstract][Full Text] [Related]
30. Reduced expression of platelet endothelial cell adhesion molecule-1 in bone marrow cells in mice after skeletal unloading. Sakuma-Zenke M; Sakai A; Nakayamada S; Kunugita N; Tabata T; Uchida S; Tanaka S; Mori T; Nakai K; Tanaka Y; Nakamura T J Bone Miner Res; 2005 Jun; 20(6):1002-10. PubMed ID: 15883641 [TBL] [Abstract][Full Text] [Related]
31. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Takahashi N; Haba A; Matsuno F; Seon BK Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802 [TBL] [Abstract][Full Text] [Related]
32. Secretogranin II expression in Ewing's sarcomas and primitive neuroectodermal tumors. Pagani A; Fischer-Colbrie R; Sanfilippo B; Winkler H; Cerrato M; Bussolati G Diagn Mol Pathol; 1992 Sep; 1(3):165-72. PubMed ID: 1342962 [TBL] [Abstract][Full Text] [Related]
33. Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Ozerdem U; Alitalo K; Salven P; Li A Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3502-6. PubMed ID: 16186326 [TBL] [Abstract][Full Text] [Related]